» Articles » PMID: 9852138

The Coactivator CBP Stimulates Human T-cell Lymphotrophic Virus Type I Tax Transactivation in Vitro

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Dec 16
PMID 9852138
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Tax interacts with the cellular cyclic AMP-responsive element binding protein (CREB) and facilitates the binding of the coactivator CREB binding protein (CBP), forming a multimeric complex on the cyclic AMP-responsive element (CRE)-like sites in the human T-cell lymphotrophic virus type I (HTLV-I) promoter. The trimeric complex is believed to recruit additional regulatory proteins to the HTLV-I long terminal repeat, but there has been no direct evidence that CBP is required for Tax-mediated transactivation. We present evidence that Tax and CBP activate transcription from the HTLV-I 21 base pair repeats on naked DNA templates. Transcriptional activation of the HTLV-I sequences required both Tax and CBP and could be mediated by either the N-terminal activation domain of CBP or the full-length protein. Fluorescence polarization binding assays indicated that CBP does not markedly enhance the affinity of Tax for the trimeric complex. Transcription analyses suggest that CBP activates Tax-dependent transcription by promoting transcriptional initiation and reinitiation. The ability of CBP to activate the HTLV-I promoter does not involve the stabilization of Tax binding, but rather depends upon gene activation properties of the co-activator that function in the context of a naked DNA template.

Citing Articles

NF-κB signaling mechanisms in HTLV-1-induced adult T-cell leukemia/lymphoma.

Harhaj E, Giam C FEBS J. 2018; 285(18):3324-3336.

PMID: 29722927 PMC: 6750271. DOI: 10.1111/febs.14492.


The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.

Forlani G, Abdallah R, Accolla R, Tosi G J Virol. 2016; 90(7):3708-21.

PMID: 26792751 PMC: 4794681. DOI: 10.1128/JVI.03000-15.


Epigenetics, drugs of abuse, and the retroviral promoter.

Shirazi J, Shah S, Sagar D, Nonnemacher M, Wigdahl B, Khan Z J Neuroimmune Pharmacol. 2013; 8(5):1181-96.

PMID: 24218017 PMC: 3878082. DOI: 10.1007/s11481-013-9508-y.


The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.

Forlani G, Abdallah R, Accolla R, Tosi G Front Microbiol. 2013; 4:234.

PMID: 23986750 PMC: 3749491. DOI: 10.3389/fmicb.2013.00234.


Complex role of microRNAs in HTLV-1 infections.

Sampey G, Van Duyne R, Currer R, Das R, Narayanan A, Kashanchi F Front Genet. 2012; 3:295.

PMID: 23251140 PMC: 3523292. DOI: 10.3389/fgene.2012.00295.